Sign In
Buy CDNA
$22.31
+0.240 (+1.09%)
At Close: Jun 03, 2026
Citigroup Inc. Acquires 41,867 Shares of CareDx Inc (NASDAQ:CDNA)
08:04am, Sunday, 07'th Jun 2020
Citigroup Inc. lifted its holdings in shares of CareDx Inc (NASDAQ:CDNA) by 500.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
State Street Corp Acquires 7,923 Shares of CareDx Inc (NASDAQ:CDNA)
07:20am, Sunday, 07'th Jun 2020
State Street Corp increased its holdings in CareDx Inc (NASDAQ:CDNA) by 0.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commissio
CareDx to Participate at the Goldman Sachs Global Healthcare Conference
11:00am, Thursday, 04'th Jun 2020
SOUTH SAN FRANCISCO, Calif., June 04, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx to Present at the Jefferies Virtual Healthcare Conference
11:00am, Thursday, 28'th May 2020
SOUTH SAN FRANCISCO, Calif., May 28, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx Presents the Latest AlloSure Data in Virtual Meetings
11:00am, Wednesday, 27'th May 2020
SOUTH SAN FRANCISCO, Calif., May 27, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
CareDx's AlloSeq Tx 17 Awarded CE Mark Approval
11:00am, Friday, 15'th May 2020
SOUTH SAN FRANCISCO, Calif., May 15, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx And Veracyte Announce Exclusive Partnership For Transplant Rejection Testing On nCounter System
12:17pm, Thursday, 14'th May 2020CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
12:15pm, Thursday, 14'th May 2020
CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
Gagnon Advisors, LLC Buys CareDx Inc, Profound Medical Corp, Enterprise Products Partners LP, ...
12:00am, Monday, 11'th May 2020Caredx Inc (CDNA) CFO Michael Brian Bell Sold $–.7 million of Shares
12:00am, Friday, 08'th May 2020CareDx Brings the Transplant Patient Community Together
11:00am, Thursday, 07'th May 2020
SOUTH SAN FRANCISCO, Calif., May 07, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
